Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127 | 1,908 | 3,323 | 6,391 | 7,186 |
| Receivables | 933 | 11 | N/A | 175 | 50 |
| TOTAL | $2,206 | $2,679 | $4,418 | $7,478 | $8,025 |
| Non-Current Assets | |||||
| PPE Net | 164 | 177 | 207 | 189 | 236 |
| Other Non-Current Assets | 188 | 229 | 270 | 310 | 351 |
| TOTAL | $352 | $406 | $477 | $499 | $587 |
| Total Assets | $2,558 | $3,085 | $4,895 | $7,977 | $8,612 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 75 | 75 | 75 | 74 | 74 |
| Accounts payable and accrued liabilities | 4,225 | 1,608 | 1,093 | 1,518 | 494 |
| Accrued Expenses | 1,895 | 1,533 | 975 | 781 | 1,256 |
| TOTAL | $6,362 | $3,383 | $2,310 | $2,537 | $1,987 |
| Non-Current Liabilities | |||||
| Long Term Debt | 44 | 63 | 82 | 101 | 119 |
| Other Non-Current Liabilities | 21 | 62 | 103 | 146 | 188 |
| TOTAL | $65 | $125 | $185 | $247 | $307 |
| Total Liabilities | $6,427 | $3,508 | $2,495 | $2,784 | $2,294 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 892 | 314 | 261 | 238 | 203 |
| Common Shares | N/A | 7 | 5 | N/A | 4 |
| Retained earnings | -336,610 | -331,698 | -324,638 | -319,676 | -314,598 |
| Other shareholders' equity | -11 | -11 | -11 | -11 | -11 |
| TOTAL | $-3,869 | $-423 | $2,400 | $5,193 | $6,318 |
| Total Liabilities And Equity | $2,558 | $3,085 | $4,895 | $7,977 | $8,612 |